Expert Ratings for Edwards Lifesciences
Portfolio Pulse from Benzinga Insights
Analysts have provided ratings for Edwards Lifesciences (NYSE:EW) over the last quarter, with a majority leaning towards bullish or somewhat bullish. The average price target is $99.92, indicating an upside from the current price of $73.985. The average price target has increased by 1.07% over the past month.
September 08, 2023 | 5:00 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Edwards Lifesciences has received mostly bullish ratings from analysts, with an average price target indicating potential upside.
The majority of analysts have given Edwards Lifesciences a bullish or somewhat bullish rating, indicating a positive outlook for the stock. The average price target is also higher than the current price, suggesting potential for growth. This could have a positive impact on the stock's price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100